Japan Tissue Engineering Company Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Japan Tissue Engineering Company Limited with three other
companies in this sector in Japan:
PhoenixBio Co Ltd
sales of 1.22 billion Japanese Yen [US$10.93 million]
SanBio Co Ltd
(1.17 billion Japanese Yen [US$10.55 million]
of which 100%
was Commercial Physical Research), and
GNI Group Limited
(1.31 billion Japanese Yen [US$11.74 million]
Japan Tissue Engineering Company Limited reported sales of ¥1.43 billion (US$12.85 million)
March of 2016.
increase of 8.3%
versus 2015, when the company's sales were ¥1.32 billion.
Sales at Japan Tissue Engineering Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 307%).
Sales of Regenerative Medicine Products Business saw an increase
8.5% in 2016, from
¥1.23 billion to ¥1.34 billion.